Message Framing and Policy Support for Front-of-package Labeling
NCT ID: NCT06296342
Last Updated: 2025-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4107 participants
INTERVENTIONAL
2024-08-09
2024-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Front-of-package Label Effects in Latine and Limited English Proficiency Populations
NCT06293963
Impact of Front-of-package Labels on Weight Bias Among Latines
NCT06293937
Impact of Front-of-package Warning Labels on Perceived Weight Stigmatization
NCT06179043
Assessing the Impact of Front-of-package Nutrient Labels
NCT06673706
Front-of-Package Nutrition Labels
NCT06516627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (No framing)
Participants will view one message about the front-of-package labeling policy. The message will display the same introductory sentence as all experimental arms, but it will not include a framed message about the objective of the front-of-package labeling policy.
No interventions assigned to this group
Information framing
Participants will view one message that frames the objective of the front-of-package labeling policy as providing nutritional information.
Exposure to information framing message
The information framing message presents the objective of the front-of-package labeling policy as providing nutritional information.
Healthier choices framing
Participants will view one message that frames the objective of the front-of-package labeling policy as encouraging consumers to make healthier choices.
Exposure to healthier choices framing message
The healthier choices framing message presents the objective of the front-of-package labeling policy as encouraging consumers to make healthier choices.
Industry framing
Participants will view one message that frames the objective of the front-of-package labeling policy as encouraging the food industry to make healthier products.
Exposure to industry framing message
The industry framing message presents the objective of the front-of-package labeling policy as encouraging the food industry to make healthier products.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure to information framing message
The information framing message presents the objective of the front-of-package labeling policy as providing nutritional information.
Exposure to healthier choices framing message
The healthier choices framing message presents the objective of the front-of-package labeling policy as encouraging consumers to make healthier choices.
Exposure to industry framing message
The industry framing message presents the objective of the front-of-package labeling policy as encouraging the food industry to make healthier products.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18-55 years old
* Residing in the United States
Exclusion Criteria
* Less than 18 or greater than 55 years old
* Not residing in the United States
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Stanford University
OTHER
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marissa G Hall, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of North Carolina at Chapel Hill's Gillings School of Global Public Health
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-0300c
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.